Using biomarkers in pulmonary arterial hypertension may be a less invasive strategy for assessing response to treatment.
Pulmonary and thoracic symptoms often coincide with initial presentation of connective tissue disease.
Pulmonary arterial hypertension is becoming a major cause of death in patients with systemic sclerosis.
Mobile devices may help patients with asthma better manage and control their disease.
Respiratory muscle dysfunction, iron deficiency, and skeletal muscle dysfunction have been implicated as mechanisms for exercise intolerance in pulmonary arterial hypertension.
Lung disease experts Athol Wells, MD, and Joshua Mooney, MD, MS, debate the diagnostic value of bronchoalveolar lavage in idiopathic pulmonary fibrosis.
Although some pregnant women discontinue their asthma medications for fear of fetal drug toxicity, they may be putting their babies at greater risk.
Pulmonary arterial hypertension tends to vary in presentation in patients of different races and ethnicities.
Prenatal factors such as intrauterine growth retardation, infection, and placental inflammation can affect lung development in neonates.
The pathogeneses of steroid insensitivity in severe, steroid-resistant asthma may unlock new potential treatments.